Human genetics and biotechnology company 23andMe has filed for Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri to facilitate a sales process.
In a press release, the company said it intends to continue operating its business throughout the sales process and no changes will be made to the way the company will store, manage or protect customer data.
Anne...
